A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a polygenic risk score. Zhao Z, Gu S, Yang Y, Wu W, et al. BMC Cancer 2024;24:73.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao Z, Gu S, Yang Y, Wu W, et al. A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a polygenic risk score. BMC Cancer 2024;24:73.
PMID: 38218803